Key facts
- It has raised $15.4M; the latest was Later Stage VC in Feb 2026.
- Notable investors include ZhenFund, TusStar Incubator, Plum Ventures, Tsinghua Holdings, Wuhan Innovation Investment — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for TrueSight Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for TrueSight Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TrueSight Technology
Developer of precision medical technologies intended for the medical industry and doctors. The company specializes in the research and development of artificial intelligence that provides doctors with liver three-dimensional reconstruction, liver segment volume measurement, and surgical path simulation based on deep learning technology, enabling doctors to make accurate surgery plans and reduce surgery risks.
- Sector
- Healthcare
- HQ
- Beijing, China
- Employees
- 17
- Website
- truesight.com.cn/
- Ownership
- Privately Held (backing)
TrueSight Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TrueSight Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TrueSight Technology in its N-PORT filings yet. We sweep new filings monthly.